Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01441206 · ClinicalTrials.gov registry record · Phase 1
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01441206 is a Phase 1 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2 participants.
The verdict
NCT01441206, a Phase 1 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the safety and dosing of rifampin in infants.
Interventions
- DRUG rifampin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01441206
The ClinicalTrials.gov registry entry for NCT01441206 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which rifampin is the first listed.
NCT01441206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01441206 about?
NCT01441206 is a clinical study titled "Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants". The purpose of this study is to learn more about the safety and dosing of rifampin in infants.
What is the current status of trial NCT01441206?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2011-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01441206?
The interventions under investigation include: rifampin (DRUG).
Who is sponsoring clinical trial NCT01441206?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.